Range
- - -
Vol / Avg.
-/1.9M
Div / Yield
-
52 Wk
3.15 - 9
Mkt Cap
153M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.25
Shares
41.3M
Outstanding
41.3M
Total Float
40M
Sector: Health Care.Industry: Pharmaceuticals
Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-08
REV
Q2 2021Est.ActualSurprise
EPS-0.240-0.250 -0.0100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Zynerba Pharmaceuticals Questions & Anwsers

Q

How do I buy Zynerba Pharmaceuticals (ZYNE) stock?

A

You can purchase shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zynerba Pharmaceuticals's (ZYNE) competitors?

Q

What is the target price for Zynerba Pharmaceuticals (ZYNE) stock?

A

The latest price target for Zynerba Pharmaceuticals (NASDAQ: ZYNE) was reported by Needham on July 1, 2020. The analyst firm set a price target for 0.00 expecting ZYNE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zynerba Pharmaceuticals (ZYNE)?

A

The stock price for Zynerba Pharmaceuticals (NASDAQ: ZYNE) is $3.71 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Zynerba Pharmaceuticals (ZYNE) pay a dividend?

A

There are no upcoming dividends for Zynerba Pharmaceuticals.

Q

When is Zynerba Pharmaceuticals (NASDAQ:ZYNE) reporting earnings?

A

Zynerba Pharmaceuticals’s $Q3 earnings are confirmed for after-market on $November 8, 2021.

Q

Is Zynerba Pharmaceuticals (ZYNE) going to split?

A

There is no upcoming split for Zynerba Pharmaceuticals.

Q

What sector and industry does Zynerba Pharmaceuticals (ZYNE) operate in?

A

Zynerba Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.